CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-11 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −1,019 | 3,057 | ||
| 2026-03-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +11,340 | $59.26 | $672K | 32,606.25 |
| 2026-03-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −11,340 | $85.93 | $974K | 21,266.25 |
| 2026-03-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −11,340 | 22,680 | ||
| 2026-02-25 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | −24,000 | $83.84 | $2.0M | 21,266.25 |
| 2026-02-22 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes | −432 | $79.78 | $34K | 33,933.91 |
| 2026-02-22 | Dahl Andrew M. SVP, Corporate Controller | Shares withheld for taxes | −176 | $79.78 | $14K | 9,089.48 |
| 2026-02-17 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes | −198 | $75.87 | $15K | 34,365.91 |
| 2026-02-16 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −199 | $75.87 | $15K | 39,699 |
| 2026-02-16 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes | −258 | $75.87 | $20K | 34,563.91 |
| 2026-02-13 | Zovighian Bernard J CEO | Gift | −2,920 | 80,976 | ||
| 2026-02-13 | Zovighian Bernard J CEO | Gift | +2,920 | 11,516.55 | ||
| 2026-02-12 | Lippis Daniel J. CVP, TAVR | Grant or award | +12,820 | 34,821.91 | ||
| 2026-02-12 | Zovighian Bernard J CEO | Option exercise | +25,350 | $59.26 | $1.5M | 106,326 |
| 2026-02-12 | Zovighian Bernard J CEO | Sale | −2,532 | $77.13 | $195K | 103,794 |
| 2026-02-12 | Zovighian Bernard J CEO | Sale | −19,898 | $76.61 | $1.5M | 83,896 |
| 2026-02-12 | Zovighian Bernard J CEO | Option exercise · Employee Stock Option (Right to Acquire) | −25,350 | 0 | ||
| 2026-01-09 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +1,019 | $59.26 | $60K | 23,020.91 |
| 2026-01-09 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −1,019 | $85.70 | $87K | 22,001.91 |
| 2026-01-09 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −1,019 | 4,076 |
Page 9 of 13 · 249 trades